S. 1157 (119th)Bill Overview

Women and Lung Cancer Research and Preventive Services Act of 2025

Health|CancerCardiovascular and respiratory health
Cosponsors
Support
Bipartisan
Introduced
Mar 26, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief

This bill requires the HHS Secretary, consulting with the Secretaries of Defense and Veterans Affairs, to conduct an interagency review on the status of lung cancer research in women and underserved populations.

The review must evaluate research gaps, opportunities to accelerate research, access to preventive services, and national education and screening strategies.

It must produce a report for Congress within two years of enactment.

Passage55/100

Low-cost, technocratic review with bipartisan potential increases prospects, but passage depends on committee action and floor scheduling.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a clear, appropriately scoped study/reporting mandate that identifies responsible agencies and specifies the content and timeline for a comprehensive review and a report to Congress. It lacks fiscal direction, detailed implementation mechanics, and safeguards for data and interagency coordination.

Contention18/100

Liberal emphasizes equity and follow-up funding for recommendations

02 · What it does

Who stands to gain, and who may push back.

Who this appears to help vs burden50% / 50%
Federal agenciesFederal agencies
Likely helped
  • Federal agenciesMay improve coordination of federal research programs on lung cancer in women and underserved groups.
  • Targeted stakeholdersCould identify gaps that lead to targeted research on environmental and genomic risk factors.
  • Targeted stakeholdersMay inform a national screening strategy to expand access for eligible women and underserved populations.
Likely burdened
  • Targeted stakeholdersImposes administrative work and analysis costs on HHS, DoD, and VA without specific funding.
  • Targeted stakeholdersA report requirement may not produce concrete policy changes or new programs by itself.
  • Federal agenciesMay duplicate existing federal or academic reviews of lung cancer research and disparities.
03 · Why people split

Why the argument around this bill splits.

Liberal emphasizes equity and follow-up funding for recommendations
Progressive90%

Likely broadly supportive.

Sees focused study on lung cancer in women and underserved groups as addressing health equity and research neglect.

Wants review to lead to concrete funding and targeted interventions.

Leans supportive
Centrist80%

Generally favorable but pragmatic.

Likes evidence-driven review and interagency approach, while wanting clarity on costs, duplication avoidance, and measurable follow-up before endorsing implementation.

Leans supportive
Conservative65%

Cautiously open but reserved.

Supports medical research and veteran health, yet wary that the review could justify expanded federal programs, mandates, or future spending without demonstrated cost-effectiveness.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood55/100

Low-cost, technocratic review with bipartisan potential increases prospects, but passage depends on committee action and floor scheduling.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No explicit funding or cost estimate included
  • Committee workload and prioritization timeline
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberal emphasizes equity and follow-up funding for recommendations

Low-cost, technocratic review with bipartisan potential increases prospects, but passage depends on committee action and floor scheduling.

Unlocked analysis

Relative to its intended legislative type, this bill is a clear, appropriately scoped study/reporting mandate that identifies responsible agencies and specifies the content and timeline for a comprehensive review and a…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis